Revive Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Revive Therapeutics has a total shareholder equity of CA$9.5M and total debt of CA$60.0K, which brings its debt-to-equity ratio to 0.6%. Its total assets and total liabilities are CA$12.9M and CA$3.3M respectively.
Key information
0.6%
Debt to equity ratio
CA$60.00k
Debt
Interest coverage ratio | n/a |
Cash | CA$708.42k |
Equity | CA$9.53m |
Total liabilities | CA$3.35m |
Total assets | CA$12.88m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 31R's short term assets (CA$990.7K) do not cover its short term liabilities (CA$3.2M).
Long Term Liabilities: 31R's short term assets (CA$990.7K) exceed its long term liabilities (CA$138.2K).
Debt to Equity History and Analysis
Debt Level: 31R has more cash than its total debt.
Reducing Debt: 31R's debt to equity ratio has increased from 0% to 0.6% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 31R has sufficient cash runway for 2 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: 31R is forecast to have sufficient cash runway for 2 months based on free cash flow estimates, but has since raised additional capital.